JPRN-UMIN000008259已完成未知
Assessment of Comorbidities & Atrial Arrhythmia Burden in Dual-Chamber Paced Patients - EMERALD Study
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 4,290
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Contraindicated for cardiac pacing, according to the ESC and ACC/AHA/HRS guidelines 2. Permanent or persistent atrial tachyarrhythmia 3. Already included in another interventional clinical study 4. Life expectancy less than 24 months 5. Not available for routine follow-up visits. 6. Inability to understand the purpose of the study or refusal to cooperate 7. Under guardianship 8. Age of less than 18 years 9. Pregnancy (Women of childbearing potential should have a negative pregnancy test prior to enrollment)
研究者
相似试验
已完成
不适用
EMERALD - AssEssment of CoMorbidities & Atrial ArRhythmiA Burden in DuaL-Chamber PaceD PatientsAtrial ArrhythmiaNCT01188356MicroPort CRM4,350
已完成
不适用
Arrhythmia Risk Stratification in a Clinical Patient Cohort and Correlation with Genotype and Environmental Modulatorsarrhythmia risk stratification1000752110007510NL-OMON37942Academisch Medisch Centrum100
尚未招募
不适用
Comorbidities in death due to COVID 19 infectioCTRI/2021/03/032276Yenepoya Medical College Hospital
尚未招募
4 期
Effects of Sitagliptin-based therapy in Type 2 diabetes patients across India.CTRI/2023/10/058953upin Pharmaceutical Ltd.
已完成
4 期
Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing TrialHypertensionAtrial FibrillationNCT00256152Abbott Medical Devices2,580